Wei Liu

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Extracorporeal Membrane Oxygenation

Systemic Lupus Erythematosus

Disease Activity

Top Venues

Clinical and translational science

Clinical pharmacology and therapeutics

Rheumatology and therapy

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Sumit Bhatnagar, Doerthe Eckert, Sven Stodtmann, In-Ho Song, Peter Wung, Wei Liu, Mohamed-Eslam F Mohamed
Population pharmacokinetics and exposure-response analyses for efficacy and safety of upadacitinib in patients with axial spondyloarthritis. Clinical and translational science 17 (2) (2024)
Sumit Bhatnagar, Louisa Schlachter, Doerthe Eckert, Sven Stodtmann, Wei Liu, Ana P Lacerda, Mohamed-Eslam F Mohamed
Pharmacokinetics and Exposure-Response Analyses to Support Dose Selection of Upadacitinib in Crohn's Disease. Clinical pharmacology and therapeutics (2024)
Sumit Bhatnagar, Doerthe Eckert, Sven Stodtmann, In-Ho Song, Peter Wung, Wei Liu, Mohamed-Eslam F Mohamed
Population pharmacokinetics and exposure-response analyses for efficacy and safety of apadacitinib in patients with axial Spondyloarthritis. Clinical and translational science 17 (2) (2024)
Neha Thakre, Aline Goebel, Insa Winzenborg, Ahmed A Suleiman, Ronilda R D'Cunha, Sven Mensing, Wei Liu, Yinuo Pang
Population Pharmacokinetic and Exposure-Response Modeling to Inform Risankizumab Dose Selection in Patients With Ulcerative Colitis. Clinical pharmacology and therapeutics 116 (3) (2024)
Sumit Bhatnagar, Doerthe Eckert, Sven Stodtmann, In-Ho Song, Peter Wung, Wei Liu, Mohamed-Eslam F Mohamed
Population pharmacokinetics and exposure-response analyses for efficacy and safety of apadacitinib in patients with axial Spondyloarthritis. Clinical and translational science 17 (2) (2024)
Sumit Bhatnagar, Doerthe Eckert, Sven Stodtmann, In-Ho Song, Peter Wung, Wei Liu, Mohamed-Eslam F Mohamed
Population pharmacokinetics and exposure-response analyses for efficacy and safety of upadacitinib in patients with axial spondyloarthritis. Clinical and translational science 17 (2) (2024)
Neha Thakre, Aline Goebel, Insa Winzenborg, Ahmed A Suleiman, Ronilda R D'Cunha, Sven Mensing, Wei Liu, Yinuo Pang
Population Pharmacokinetic and Exposure-Response Modeling to Inform Risankizumab Dose Selection in Patients With Ulcerative Colitis. Clinical pharmacology and therapeutics (2024)
Ryota Kikuchi, Yuli Qian, Mohamed Badawi, John P Savaryn, Shashikanth Gannu, Ann Eldred, Shuai Hao, Ahmed Hamed Salem, Wei Liu, Cheri E Klein, Mohamed-Eslam F Mohamed
Coproporphyrin-I as a Selective OATP1B Biomarker Can Be Used to Delineate the Mechanisms of Complex Drug-Drug Interactions: Cedirogant Case Study. Clinical pharmacology and therapeutics (2024)
Sumit Bhatnagar, Doerthe Eckert, Sven Stodtmann, In-Ho Song, Peter Wung, Wei Liu, Mohamed-Eslam F Mohamed
Population pharmacokinetics and exposure-response analyses for efficacy and safety of upadacitinib in patients with axial spondyloarthritis. Clinical and translational science 17 (2) (2024)
Mohamed Ismail, Eva Doelger, Doerthe Eckert, Alan D Irvine, Alvina D Chu, Henrique D Teixeira, Wei Liu, Ahmed Nader
Population Pharmacokinetic and Exposure-Response Modeling to Inform Upadacitinib Dose Selection in Adolescent and Adult Patients with Atopic Dermatitis. British journal of clinical pharmacology (2023)
Ahmed Abbas Suleiman, Aline Goebel, Sumit Bhatnagar, Ronilda D'Cunha, Wei Liu, Yinuo Pang
Population Pharmacokinetic and Exposure-Response Analyses for Efficacy and Safety of Risankizumab in Subjects with Active Crohn's Disease. Clinical pharmacology and therapeutics (2022)
Neha Thakre, Ronilda R D'Cunha, Aline Goebel, Wei Liu, Yinuo Pang, Ahmed A Suleiman
Population Pharmacokinetics and Exposure-Response Analyses for Risankizumab in Patients with Active Psoriatic Arthritis. Rheumatology and therapy 9 (6) (2022)